Implementation of the Procalcitonin Assay in a Rural Hospital

被引:3
作者
Cole, Jennifer L. [1 ]
机构
[1] Vet Hlth Care Syst Ozarks, Fayetteville, AR USA
关键词
procalcitonin; rural hospital; antibiotic stewardship;
D O I
10.1177/0018578718762128
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective: Most positive studies in procalcitonin (PCT) utilization were done in large, tertiary medical centers. Furthermore, there is a paucity of data describing the implementation process. This article is the first to describe in detail the implementation process and initial outcomes after 6 months of PCT testing in a rural, 65-bed, primary hospital. Methods: Education before and during PCT implementation as well as facility rollout are described. Initial outcomes were assessed using a before and after quasi-experimental study design comparing 2 identical 6-month time periods: May to October 2016 and May to October 2017. Antibiotic consumption is described with days of therapy (DOT) per 1000 patient days (PD). Antimicrobial purchasing costs, admission rates, and length of stay (LOS) are also compared. Results: Antimicrobial consumption was variable with the greatest reduction at 6 months: 856 DOT/1000 PD before versus 576 DOT/1000 PD after (P < .0001). Admission rates and LOS were unaffected. There was no associated savings in antibiotic purchasing costs: $114 189.79 before and $139 829.26 after (difference +$25 639.47). Conclusion: Although implementation of PCT testing is feasible in a rural health care facility, after 6 months, it was associated with a marginal decrease in antibiotic consumption with no decrease in admission rates, LOS, or antibiotic cost savings.
引用
收藏
页码:395 / 402
页数:8
相关论文
共 47 条
[1]  
[Anonymous], 2016, JT COMM PERSPECT, V36, P8
[2]   Effect of Procalcitonin Testing on Health-care Utilization and Costs in Critically Ill Patients in the United States [J].
Balk, Robert A. ;
Kadri, Sameer S. ;
Cao, Zhun ;
Robinson, Scott B. ;
Lipkin, Craig ;
Bozzette, Samuel A. .
CHEST, 2017, 151 (01) :23-33
[3]  
Barlam TF, 2016, CLIN INFECT DIS, V62, pE51, DOI 10.1093/cid/ciw118
[4]   Pyocalcitonin assay in systemic inflammation, infection, and sepsis: Clinical utility and limitations [J].
Becker, Kenneth L. ;
Snider, Richard ;
Nylen, Eric S. .
CRITICAL CARE MEDICINE, 2008, 36 (03) :941-952
[5]   Provider Decisions to Treat Respiratory Illnesses with Antibiotics: Insights from a Randomized Controlled Trial [J].
Branche, Angela R. ;
Walsh, Edward E. ;
Jadhav, Nagesh ;
Karmally, Rachel ;
Baran, Andrea ;
Peterson, Derick R. ;
Falsey, Ann R. .
PLOS ONE, 2016, 11 (04)
[6]   Choosing Wisely Helping Physicians and Patients Make Smart Decisions About Their Care [J].
Cassel, Christine K. ;
Guest, James A. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (17) :1801-1802
[7]  
Centers for Disease Control and Prevention, 2017, IMPL ANT STEW COR EL
[8]  
Cole Jennifer, 2017, Fed Pract, V34, P14
[9]   Back to Basics: Deciphering a Procalcitonin Picture in Clinical Practice [J].
Cole, Jennifer L. ;
Stark, Jennifer E. .
INFECTIOUS DISEASES IN CLINICAL PRACTICE, 2018, 26 (06) :E45-E47
[10]   Provider perceptions on procalcitonin testing: a survey to tailor facility implementation [J].
Cole, Jennifer L. .
INFECTION, 2017, 45 (06) :925-926